The &phis;C31 Integrase System for Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|6|6|633-645

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.6, Iss.6, 2006-12, pp. : 633-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Applications of the PhiC31 Integrase System

By  

Current Gene Therapy, Vol. 11, Iss. 5, 2011-10 ,pp. : 375-381

Bentham Science Publishers

Access to resources Recommend Favorite

Integrase-Deficient Lentivirus: Opportunities and Challenges for Human Gene Therapy

By  

Current Gene Therapy, Vol. 14, Iss. 5, 2014-10 ,pp. : 352-364

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Sigma-1 (sig1) Receptor Antagonists: Emerging Target for the Treatment of Neuropathic Pain

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 3, 2009-09 ,pp. : 172-183

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Peripheral Nervous System Diseases

By  

Current Gene Therapy, Vol. 7, Iss. 4, 2007-01 ,pp. : 239-248

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuroendocrine System as a Model to Evaluate Experimental Gene Therapy

By  

Current Gene Therapy, Vol. 6, Iss. 1, 2006-02 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite